Fig. 3From: Risk factors for pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment: a single-institute analysisPrognoses of the patients with or without pneumothorax. Prognoses of the patients with or without pneumothorax: overall survival (OS) and progression-free survival (PFS)Back to article page